TFR Capital, LLC.
Source: SEC Form 13F · as of Mar 2026TFR Capital, LLC. holds 13 biotech & pharma companies tracked by BioSniper, totaling $21.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$21.0M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 5,586 | $5.1M |
| ABBVAbbVie Inc. | 17,516 | $3.8M |
| JNJJOHNSON & JOHNSON | 10,670 | $2.6M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 5,037 | $2.2M |
| MCKMcKesson Corporation | 2,553 | $2.2M |
| CORCencora Inc. | 6,055 | $1.9M |
| MRKMerck & Co., Inc. | 6,448 | $776K |
| ABTABBOTT LABORATORIES | 4,680 | $480K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,709 | $462K |
| PMPhilip Morris International Inc | 2,733 | $452K |
| GILDGILEAD SCIENCES, INC. | 2,325 | $324K |
| AMGNAMGEN INC | 809 | $285K |
| BMYBRISTOL MYERS SQUIBB CO | 4,471 | $271K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.